Elena Mead

8.7k total citations · 1 hit paper
25 papers, 2.4k citations indexed

About

Elena Mead is a scholar working on Oncology, Surgery and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Elena Mead has authored 25 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 5 papers in Surgery and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Elena Mead's work include CAR-T cell therapy research (18 papers), Ultrasound in Clinical Applications (4 papers) and Hemodynamic Monitoring and Therapy (3 papers). Elena Mead is often cited by papers focused on CAR-T cell therapy research (18 papers), Ultrasound in Clinical Applications (4 papers) and Hemodynamic Monitoring and Therapy (3 papers). Elena Mead collaborates with scholars based in United States, Italy and Thailand. Elena Mead's co-authors include Bianca Santomasso, Craig S. Sauter, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain, Jae H. Park, Brigitte Sénéchal, Xiuyan Wang, Yongzeng Wang and Kevin J. Curran and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Elena Mead

22 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

2018 1.8k citations Jae H. Park, Isabelle Rivière et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena Mead United States	10	2.1k	597	558	556	524	25	2.4k
Nicholas Tschernia United States	7	2.1k 1.0×	656 1.1×	558 1.0×	590 1.1×	614 1.2×	20	2.3k
D. Stroncek United States	5	2.1k 1.0×	652 1.1×	556 1.0×	580 1.0×	665 1.3×	12	2.3k
Sherry Adkins United States	9	1.9k 0.9×	472 0.8×	543 1.0×	451 0.8×	503 1.0×	14	2.1k
Armin Ghobadi United States	20	1.6k 0.8×	385 0.6×	295 0.5×	493 0.9×	460 0.9×	152	2.0k
Barbara Camisa Italy	13	1.8k 0.8×	533 0.9×	518 0.9×	598 1.1×	1.2k 2.2×	27	2.6k
Rammurti T. Kamble United States	17	1.4k 0.6×	508 0.9×	360 0.6×	545 1.0×	514 1.0×	66	2.1k
Olalekan O. Oluwole United States	25	2.1k 1.0×	428 0.7×	393 0.7×	604 1.1×	508 1.0×	154	2.4k
Haruko Tashiro Japan	13	1.3k 0.6×	449 0.8×	362 0.6×	477 0.9×	536 1.0×	57	1.6k
Jonathan D. Fish United States	17	985 0.5×	362 0.6×	290 0.5×	467 0.8×	476 0.9×	32	1.6k
Monica Casucci Italy	16	1.6k 0.7×	466 0.8×	495 0.9×	527 0.9×	654 1.2×	35	1.9k

Countries citing papers authored by Elena Mead

Since Specialization

Citations

This map shows the geographic impact of Elena Mead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Mead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Mead more than expected).

Fields of papers citing papers by Elena Mead

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Mead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Mead. The network helps show where Elena Mead may publish in the future.

Co-authorship network of co-authors of Elena Mead

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Mead. A scholar is included among the top collaborators of Elena Mead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Mead. Elena Mead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Jae H., Karthik Nath, Sean M. Devlin, et al.. (2023). CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results. Nature Medicine. 29(7). 1710–1717. 99 indexed citations

Nath, Karthik, Sean M. Devlin, Craig S. Sauter, et al.. (2023). A Phase II Trial of Prophylactic Anakinra to Prevent Neurotoxicity in Patients Receiving Anti-CD19 CAR T-Cell Therapy for Relapsed or Refractory Lymphoma: Final Results from Cohort 2. Blood. 142(Supplement 1). 357–357. 1 indexed citations

Pastores, Stephen M., et al.. (2022). 361: PROFOUND EPISTAXIS IN CYTOKINE RELEASE SYNDROME FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY. Critical Care Medicine. 51(1). 166–166.

Park, Jae H., Craig S. Sauter, M. Lia Palomba, et al.. (2021). A Phase II Study of Prophylactic Anakinra to Prevent CRS and Neurotoxicity in Patients Receiving CD19 CAR T Cell Therapy for Relapsed or Refractory Lymphoma. Blood. 138(Supplement 1). 96–96. 24 indexed citations

Wudhikarn, Kitsada, M. Lia Palomba, Martina Pennisi, et al.. (2020). Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma. Blood Cancer Journal. 10(8). 79–79. 161 indexed citations

Wudhikarn, Kitsada, Martina Pennisi, Marta García‐Recio, et al.. (2020). DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality. Blood Advances. 4(13). 3024–3033. 85 indexed citations

Brown, Anne Rain, Prabalini Rajendram, Megan M. Herr, et al.. (2020). 482: Chimeric Antigen Receptor (CAR) Cell Patients Admitted to the ICU: The CAR-ICU Initiative Experience. Critical Care Medicine. 49(1). 232–232. 1 indexed citations

Herr, Megan M., Cristina Gutiérrez, Anne Rain Brown, et al.. (2020). 44: Cytokine Release Syndrome in Chimeric Antigen Receptor T-Cell Therapy: The CAR-ICU Experience. Critical Care Medicine. 49(1). 23–23.

Jain, Tania, Andrea Knežević, Martina Pennisi, et al.. (2020). Hematopoietic Recovery Following Chimeric Antigen Receptor T Cell (CAR T) Therapy in Hematological Malignancies. Biology of Blood and Marrow Transplantation. 26(3). S63–S64. 1 indexed citations

10.

Smith, Eric L., Sham Mailankody, Mette Stæhr, et al.. (2019). BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy. Cancer Immunology Research. 7(7). 1047–1053. 67 indexed citations

11.

Shah, Gunjan L., Jae H. Park, Craig S. Sauter, et al.. (2019). Thirty Day Resource Utilization after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 25(3). S38–S39. 2 indexed citations

12.

Fischer, Gregory W., et al.. (2019). Next Generation of Cancer Treatments: Chimeric Antigen Receptor T-Cell Therapy and Its Related Toxicities: A Review for Perioperative Physicians. Anesthesia & Analgesia. 129(2). 434–441. 13 indexed citations

13.

Santomasso, Bianca, Jae Hong Park, Isabelle Rivière, et al.. (2018). Neurotoxicity Associated with CD19-specific Chimeric Antigen Receptor T cell Therapy for Adult Acute Lymphoblastic Leukemia (B-ALL) (S23.008). Neurology. 90(15_supplement). 3 indexed citations

14.

Chen, Leon, et al.. (2018). A Patient in Respiratory Distress After Esophagectomy. CHEST Journal. 154(6). e157–e160. 2 indexed citations

15.

Chen, Leon, et al.. (2018). A Lung Cancer Patient With Respiratory Insufficiency and Hemodynamic Instability. CHEST Journal. 153(3). e49–e52. 3 indexed citations

16.

Shah, Gunjan L., Jae H. Park, Craig S. Sauter, et al.. (2018). Resource Utilization Early after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies. Blood. 132(Supplement 1). 616–616. 1 indexed citations

17.

Chen, Leon, et al.. (2017). A Patient on Airway Pressure Release Ventilation With Sudden Hemodynamic Collapse. CHEST Journal. 152(1). e7–e9. 3 indexed citations

18.

Park, Jae Hong, Isabelle Rivière, Xiuyan Wang, et al.. (2017). Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy.. Journal of Clinical Oncology. 35(15_suppl). 7008–7008. 13 indexed citations

19.

Chen, Leon, et al.. (2017). 361: POINT-OF-CARE ULTRASOUND TRAINING PROGRAM FOR CRITICAL CARE MEDICINE ADVANCED PRACTICE PROVIDERS. Critical Care Medicine. 46(1). 163–163. 3 indexed citations

20.

Santomasso, Bianca, Jae Hong Park, Isabelle Rivière, et al.. (2017). Biomarkers associated with neurotoxicity in adult patients with relapsed or refractory B-ALL (R/R B-ALL) treated with CD19 CAR T cells.. Journal of Clinical Oncology. 35(15_suppl). 3019–3019. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact